Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
NeuroPace, Inc. (NPCE) had Cost of Goods Sold of $4.02M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$22.07M |
|
$-6.69M |
|
|
Cost of Goods Sold |
$4.02M |
$18.05M |
|
$27.64M |
|
$-5.57M |
|
$-1.12M |
|
$-6.69M |
|
$-6.69M |
|
$-6.69M |
|
$-6.69M |
|
$-6.69M |
|
$-6.69M |
|
$-5.57M |
|
$-4.99M |
|
33.72M |
|
33.72M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$86.98M |
|
$1.28M |
|
$11.92M |
|
$98.90M |
|
$16.17M |
|
$59.02M |
|
$68.28M |
|
$84.44M |
|
$14.45M |
|
$14.45M |
|
$14.45M |
|
33.91M |
|
| Cash Flow Statement Financials | |
$-5.90M |
|
$-0.12M |
|
$-0.17M |
|
$21.81M |
|
$15.63M |
|
$-6.18M |
|
$2.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.38 |
|
-- |
|
-- |
|
0.80 |
|
4.08 |
|
81.78% |
|
-25.23% |
|
-25.23% |
|
-- |
|
-30.31% |
|
-30.31% |
|
$-6.02M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
0.24 |
|
1.49 |
|
60.31 |
|
-46.28% |
|
-46.28% |
|
-6.76% |
|
-9.10% |
|
$0.43 |
|
$-0.18 |
|
$-0.17 |
|